Rapid, low-friction cardio-metabolic health screening for employer wellness.
ViBo Health is developing DigiScan™, a Metabolic Intelligence Platform designed to help employers increase participation and engagement in wellness programs through rapid, low-friction cardio-metabolic health screening.
ViBo Health is developing DigiScan™, a Metabolic Intelligence Platform for employer health and preventive care. DigiScan combines patented magnetic resonance spectroscopy (MRS), proprietary signal processing, and AI-driven analytics to generate objective cardio-metabolic insights from a rapid, non-invasive finger scan.
The company’s initial focus is helping self-insured employers improve participation, engagement, and adherence within existing wellness programs by reducing the friction associated with traditional health screening. Through accessible longitudinal cardio-metabolic monitoring, DigiScan is designed to reinforce healthy behaviors, provide meaningful feedback on lifestyle changes, and support earlier awareness of meaningful physiological changes.
ViBo Health is advancing its technology toward employer pilot deployments while executing its FDA regulatory strategy and expanding its intellectual property portfolio.
Our mission is to transform how and why our health is tracked, increasing awareness of cardio-metabolic health and empowering people with actionable recommendations so they can lead healthier and more fulfilling lives.
Our long-term vision is to provide an early warning system that enables earlier recognition of meaningful physiological changes and supports proactive health management.
Employers continue to invest heavily in wellness programs, yet participation, engagement, and long-term adherence remain persistently low. Traditional health screening is often inconvenient, episodic, and provides limited objective feedback that reinforces healthy behavior.
ViBo Health believes that reducing friction and improving access to objective cardio-metabolic information can help employers increase participation while enabling individuals to make more informed lifestyle decisions and engage earlier with preventive health.
DigiScan™ is a rapid, non-invasive Metabolic Intelligence Platform that combines magnetic resonance spectroscopy, proprietary sensing technologies, advanced signal processing, and artificial intelligence to generate objective cardio-metabolic insights from a simple finger scan.
Designed for workplace deployment, DigiScan aims to make cardio-metabolic monitoring fast, accessible, and repeatable, supporting longitudinal health tracking rather than isolated point-in-time measurements.
DigiScan integrates multiple proprietary technologies, including:
Generated using the advanced DigiScan prototype.
Six Letters of Intent, including two multinational organizations.
Active collaborations with UCLA and Los Alamos National Laboratory; technology development supported by NIST and the State of New Mexico.
FDA 510(k) pathway established with MedTech Impact Partners; three patent families filed.
Founder & CEO
ViBo Health combines expertise in medical devices, magnetic resonance technologies, AI, commercialization, and regulatory strategy through an experienced team of entrepreneurs, engineers, clinicians, and advisors.
ViBo Health is currently raising a $3 million Seed round to complete its MVP, initiate employer pilot deployments, and advance FDA regulatory activities.
ViBo Health is developing DigiScan™, a Metabolic Intelligence Platform designed to improve participation, engagement, and adherence in employer wellness programs through rapid, non-invasive cardio-metabolic health screening. Combining magnetic resonance spectroscopy, proprietary signal processing, and AI-driven analytics, DigiScan is being developed to generate objective cardio-metabolic insights that reinforce healthy behaviors, support longitudinal health monitoring, and enable more proactive approaches to preventive health.
DigiScan™ is currently under development.
DigiScan™ is investigational and has not been cleared or approved by the U.S. Food and Drug Administration for the diagnosis, treatment, cure, mitigation, or prevention of any disease.
For company background, investor inquiries, or media requests, contact ViBo Health.